OmniAb to Report Third Quarter 2026 Financial Results on October 30
Business Wire•14/10/2026•16:05 ET
0
Key Highlights
- ➤OmniAb will report Q3 2026 financial results before U.S. markets open October 30
- ➤Conference call discussing results and business updates starts at 8:00 a.m. Eastern October 30
- ➤OmniAb licenses antibody discovery technology to pharmaceutical, biotech, and academic partners
OmniAb to Report Third Quarter 2026 Financial Results on October 30
OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced the Company will report financial results for the three and nine months ended September 30, 2026, before the open of the U.S. financial markets on Friday, October 30, 2026, and will hold a conference call that same day beginning at 8:00 a.m. Eastern time.
Get started
Create a free account to read the full story.